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Radiofrequency Catheter Cure of 
Idiopathic Ventricular Tachycardia 
First Experience in Hawaii 
-
Edward N. Shen MD 
Radiofrequency catheter ablation is a well-established tech-
nique in the therapy of many forms of supraventricular 
tachyarrhythmias. Its usage in ventricular arrhythmias is little 
known. This is a report of its first usage in Hawaii in the treatment 
of 2 specific forms of ventricular tachycardia in 5 patients without 
structural heart disease. A cure was achieved in 4 of the 5 
patients. 
Introduction 
Therapy for ventricular tachycardia (VT) has traditionally 
been problematic. Drugs have low efficacy and a high side effect 
profile, including life-threatening proarrhythmia.1•2 Device 
therapy is effective, but is at best suppressive with considerable 
cost and morbidity, and the long-term effectiveness still awaits 
better definition with randomized, controlled trials~ Surgery 
eliminates the arrhythmia circuit in selected patients, but incurs 
high cost, morbidity, and acute mortality (mean 12% )~Catheter 
ablation, pioneered by Professor Melvin Scheinman from l]ni-
versity of California at San Francisco, is a major step forward in 
the treatment of arrhythmias,6 promising cure with abbreviated 
hospitalization and lower cost. This technique initially em-
ployed direct current (DC} energy, and its usage was confmed to 
supraventriculartachyarrhythmias. Hartzler, the renowned coro-
nary angioplasty expert, was the first to report DC catheter 
ablation for VT.7 
Unfortunately, this approach is plagued by several serious 
problems, including cardiac perforation and cardiogenic shock. 
In large part, these complications are due to the nature of the 
energy source-DC discharge is relatively uncontrolled, and 
the release of an electrical charge in blood causes electrolysis 
and gas formation, which in turn can lead to barotrauma. In 
comparison, catheter ablation with radio frequency (RF) is more 
controlled and gives rise to discrete lesions with well-demar-
cated borders, without gas formation or destruction of the blood 
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elements. Its usage in the past several years has already 
revolutionalized the therapy for supraventricular tachycardias 
(SVT).S-10 The experience with this form of energy in VT 
ablation still is very limited. 
The following report of a consecutive series of 5 patients 
demonstrates the usefulness of the technique in the elimination 
of2 unusual forms ofVT, both occuring in patients without overt 
structural heart disease. These 2 arrhythmias arise from the right 
ventricular outflow (RVOn or from the basal left ventricle 
(LV}, at the region of the posterior fascicle. 
Materials and Methods 
To be eligible for the procedure, a patient must have signifi-
cantly symptomatic arrhythmia which is also documented by 
ECG or Holter monitoring. To rule out organic heart disease as 
a cause for the VT, the patient would need to have a normal 
treadmill test and echocardiogram, or a normal cardiac 
catheterization. If the VTwereofRVorigin, anMRI scan would 
be performed to rule out arrhythmogenic RV dysplasia. 
After informed consent is obtained, the patient would undergo 
a baseline electrophysiologic study. In most cases ( 4/5 patients), 
the ablative attempt was performed in the same procedure as the 
baseline study. Quadripolar electrode catheters were introduced 
percutaneously through sheaths inserted into the left or right 
femoral veins by the Seldinger technique. They were variably 
positioned across the tricuspid valve for His bundle recordings, 
in the high right atrium, and in the right ventricle, generally in the 
apex. On one occasion, a catheter was advanced into the coro-
nary sinus to outline the mitral annulus. In the baseline study, VT 
induction was performed by RV overdrive pacing or by pro-
grammed stimulation using a basic drive train of 8 beats (at cycle 
lengths of 500 or 400 milliseconds) and with up to 3 ventricular 
extrastimuli. If programmed electrical stimulation (PES) was 
unsuccessful, an isoproterenol infusion would be given at 1 meg 
to 4 meg per minute, and PES repeated as necessary. 
After the tachycardia was induced, a 12 lead ECG was ob-
tained to defme the tachycardia morphology (Fig 1). The ven-
tricular nature of the tachycardia was demonstrated by either 
ventriculo-atrial dissociation or retrograde Hisian depolariza-
tion. Then endocardial activation mapping would be performed. 
In the case of the fascicular tachycardia, another quadripolar 
catheter would be introduced into the left ventricle through the 
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FJg 1.-lnduced ventricular tachycardia from case 1 (identical to clinical tachycardia) 
arisinq from basal Inferior left venlricfe. Note right bundle block configufalion wilh 
supenor axis. 
aortic valve, via femoral arterial access. After the origin of the 
VT was approximately determined, the mapping catheter was 
substituted with the ablation catheter, which was also a 
quadripolar electrode catheter but with an enlarged deflectable 
4 mm or 5 mm tip (Mansfield or BPI). This was advanced to the 
site of presumed VT focus (RVOT or basal LV). 
Finer defmition of tachycardia origin was performed by pace 
mapping-finding a site at which pacing with the ablation 
catheter tip could produce a QRS morphology which had 12 out 
of 12lead ECG concordance with that of the induced tachycar-
dia itself (Fig 2). 
RF energy was then applied at the site defined by the best 
available pace map, generally employing 40 to 70 volts ( 15 to 50 
watts) delivered from the large tip of the ablation catheter to a 
topical patch on the patient's back (Fig 3). Energy delivery 
would be halted immediately if the impedance measured should 
rise excessively, as this would suggest the formation of a 
coagulum (charred tissue-clot) which should be scraped off the 
catheter tip before further energy could be given. Each applica-
tion of energy would last 30 to 60 seconds. 
After each delivery, programmed stimulation was repeated. If 
tachycardia was not inducible, isoproterenol infusion and PES 
would be repeated and continued for a total duration of 30 
minutes. Tile procedure was terminated if no single repetitive 
beat was inducible. All patients received intraveous heparin 
(3000 units at initiation and 1000 additional units every hour). 
Post procedure, the patient would be monitored for at least 24 
hours. Cardiac enzymes and an echocardiogram would be ob-
tained the next morning to rule out significant myocardial injury 
or structural damage. Procedural success is defined as 
noninducibility post ablation. Clinical success is defmed as a 
complete absence of symptoms on follow-up and no arrhythmia 
documented by ambulatory monitioring. 
Results 
Five patients underwent the procedure, and their characteris-
tics and procedural successes are listed in Table 1. 
Two patients (Cases 1 and 5) had fascicular tachycardia. with 
the VT origin localized to the LV basal inferior septum. The 
morphology was right bundle branch block with superior axis 
-
Fig 2.- Pace map procb:ed bV pacing from the~ of the ablation calhet8r In Case 1. 
Nole 12 out of 12 ECG lead concordance wilh the tachycardia recorded In Fig 1. 
fig 3.- Catheter poalllons In Case 1 (In 30 degree right anlerior oblicJie PIOiection). 
To facilllale a stable calhet8r poslllon, the abla6on catheter was coiled b8ck !rom the 
apex. CS-coronary sinus/catheter (outlines the milral annulus), RF~ 
ablation catheter (with enlarged~ on the basallnferi« sep1um of the left ventricle), 
RV-righl ventricular calheter. 
(Fig 1 ). In Case 1, tachycardia was easily inducible by atrial 
pacing. In the same case, HV interval was -15 milliseconds, 
consistent with retrograde Hisian depolarization from the left 
ventricle. In both cases, sustained tachycardia was easily induc-
ible and the induced tachycardia was readily terminable with 
intraveous verapamil but not with adenosine. Procedural suc-
cess was very easily attained with 2 RF applications in Case 1 
and with only 1 in Case 5. Clinical success continued during 
follow up. 
Three patients (Cases 2, 3, and 4) had RVOT tachycardia. and 
the VT focus was localized to the RVOT anteriorly, to sites just 
below the pulmonic valve. The morphology was left bundle 
branch block with inferior axis (Fig 4 ). Induction of tachycardia 
in all 3 cases required isoproterenol facilitation, and the VT 
induced tended to be nonsustained. Procedural success was 
quite easily achieved in Cases 2 and 4 and clinical success 
persisted in follow-up. In Case 3, procedural success was 
achieved in the fmt session after 8 applications. A lower-than-
average amount of power (15 W) was used because of chest pain 
associated with each application. Unexpectedly, nonsustained 
VT recurred the same evening. The patient underwent a second 
ablative procedure the next day; however, despite vigorous 
attempts, not a single beat was inducible to serve as a template 
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TABLE 1.-Series of 5 consecutive patients without organic heart disease who underwent radiofrequency catheter ablation for ventricular tachycardia. The cases were 
arranged in chronological order. Case 1 was ablated on June 3, 1992. 
Case No Age/Sex Symptoms Tachycardia Rate Drugs Tried NoRF Success/ 
Morphology (Energy) Follow-up 
1 28/M p,sob,cp RBBB,sup 210 P,V 2 ~~ + 29m 2 56/M d LBBB,inf 250 7 l~ + 20m 3 28/F p, cp, d, s LBBB, inf 250 14 16m 4 55/M d,f LBBB, inf 230 1 + 7m 
5 15/M p,cp,d RBBB,sup 170 1 (36 + 7m 
Abbreviations (cp=Chest pain, d=dizziness, F=female, f=fatigue, inf=inferior axis, LBBB=Ieft bundle branch block. M=male, m=months P=propanolol Pt=patient Rate=beats per minute 
RBBB=right bundle branch block, Rf,.radiofrequency applications, S=syncope, sob=shortness of breath, sup:superior axis, v,.verapa'mn). ' ' 
for repeat ablation. Nonetheless, 6 RF applications were given 
"blindly" at the same radiological location recalled from the 
prior study. Afterward, the patient had uniform ventricular 
ectopy without runs. She was briefly treated with sotalol, then 
she continued without antiarrhythmic therapy and was essen-
tially symptom-free on follow-up. 
In all cases, there was a mild rise in MB CK but the total CK 
remained in the normal range, consistent with a small amount of 
myocardial injury. The echocardiograms were all normal, show-
ing no wall motion abnormality, pericardia! effusion or valvular 
abnormality. There were no complications. 
Discussion 
Tachycardia Mechanism and Clinical Features.-Fascicu-
lar tachycardia is rare. First described in 1984 by Belhassen! 1 its 
location in the left posterior f~icle or left posterior inferior 
septum is suggested by the morphology of the tachycardia, the 
range of HV intervals ( + 15 to -20 milliseconds, consistent with 
retrograde depolarization of the His bundle from the ventricle) 
and, as in our cases, by endocardial activation mapping and pace 
mapping. Typically, such a patient does not have organic heart 
disease, 12 in clear distinction from the majority of VT patients 
who have scarred ventricles from prior myocardial infarction or 
cardiomyopathies to serve as substrate. 
Tachycardia mechanism has not been clearly defmed. The 
location in or close to the conduction system may explain why 
there is such a high prevalence of induction by atrial stimulation 
(versus most other VTs that are inducible only through the 
ventricles). This may be possible simply because of geometric 
proximity. The induction by PES would argue against abnormal 
automaticity and favor reentry, whereas the very high 
supressibility by verapamil has suggested a role by 
afterdepolarizations. Indeed, there has been 1 case of fascicular 
tachycardia reported with digoxin toxicity in which the tachy-
cardia exhibited certain characteristics that supported triggered 
activity.13 The latest evidence favors reentry. This tachycardia 
has been shown to entrain with constant fusion, and also with 
progressive fusion at shorter pacing cycle lengths.1• Addition of 
verapamil has prolonged the conduction delay during entrain-
ment. Thus reentry with some zone of calcium current depen-
dent slow conduction is a very feasible unifying hypothesis. 
There is some recent evidence to suggest that the tachycardia 
-
Fig 4.-Ventricular tachycardia from Case 2 arising from right ventricular outflow tract. 
Note left bundle branch block configuration with inferior axis. 
arises from the Purkinje network itself. 
RVOT tachycardia is probably not as rare as fascicular tachy-
cardia. It was described as early as 1922 by Gallavardin!5 was 
named in 1947 by Parkinson and Pappas repetitive paroxysmal 
tachycardia,16 and more recently as repetitive monomorphic 
ventricular tachycardia.t'·19 A typical patient also does not have 
organic heart disease. This tachycardia generally presents as 
frequent nonsustained salvos of wide complex tachycardia, 
frequently with minimal symptoms. In 20% of cases, the tachy-
cardia was sustained (>30 seconds).20 What distinguishes this 
tachycardia from the rest is its easy precipitation by stress or 
exercise. It is not readily provokable by PES and frequently 
requires isoproterenol for induction, as in our cases. The mecha-
nism is probably abnormal automaticity but triggered activity 
also has been suggested in view of its response to intraveous 
adenosine (which antagonizes catecholamine-induced stimula-
tion of cyclic-AMP, believed to have a role in calcium overload-
mediated delayed afterdepolarizations and triggering). There is 
an exceptionally high response to beta-adrenergic blockers, 
though type 1 antiarrhythmic agents and veraparnil also work 
well should drug therapy be desired. 
The prognosis of patients who have these 2 forms of VT is 
unclear, as both tachycardias are relatively uncommon and there 
are no long-term follow-up studies. There has been 1 reporf1 of 
a young patient with persistent fascicular tachycardia who 
HAWAII MEDICAL JOURNAL, VOL. 53, NOVEMBER 1994 
3t2 
developed a dilated cardiomyopathy and suffered an embolic 
cerebral transient ischemic attack. The cardiac enlargement 
reverted following successful treatment with verapamil. Thus, it 
is probably not benign, though unlikely to be as malignant as the 
typical VT found in an older patient with prior myocardial 
infarctions. RVOT tachycardias have a benign prognosis in 
terms of mortality, with no deaths or worsening of symptoms 
with follow-up of 6 months to 8 years in 1 series.'8 
Efficacy of Pace Mapping and RF Catheter Ablation in VT 
without Organic Heart Disease.-The lesion caused by an RF 
application is quite shallow. Its efficacy in fascicular and RVOT 
tachycardia suggests that the tachycardia focus or the vulnerable 
portion in the reentrant circuit is at or very close to the endocar-
dium. The zone also is probably quite small, thus allowing for 1 
well-placed lesion to annihilate the tachycardia. The lack of 
scarring in an otherwise normal ventricle would ensure less 
distortion and enable activation mapping or pace mapping to 
localize the focus more accurately. In our cases, a 12 out of 12 
lead concordant pace map virtually guaranteed success (the lone 
failure in Case 3 might be due to insufficient power employed). 
By comparison, the circuit in post-infarction or cardiomyopathy-
related VT is frequently fairly large and may take various 
configurations and run very deep subendocardially, thus theo-
retically more difficult to map and ablate by RF. It stands to 
reason why ablation for ischemic type VT is far less efficacious, 
even in the most experienced centers.22 
Comparison with other Catheter Interventional Tech-
niques.-Percutaneous transluminal coronary angioplasty 
(PTCA) has been widely embraced as a standard of therapy for 
obstructive coronary artery disease, even though it is, in most 
cases, a palliative procedure with significant complications 
including death ( .5% to 1% ), abrupt vessel closure and infarction 
(3% to 5% ), and other problems such as stroke, renal dysfunc-
tion with iodinated contrast load, and vascular damage. This is 
especially remarkable in the face of a recurrence rate of 25% to 
60% at 6 months, with the known fact that there is no difference 
in prognosis between medical and surgical (likewise PTCA) 
therapy for 1 or 2-vessel disease-by far the majority of cases 
undergoing the procedure. RF catheter ablation (for VT and 
SVT) by comparison is far superior, mainly because it is curative 
with a much lower complication rate (only 1 myocardial infarction 
and 1 death reported in the world literature'0.23) and at a far lower 
cost (acutely, no surgeon or operating room standby; chroni-
cally, no medications, no emergency room visits, no repeat 
procedures). The more than 90% success rate could be obtained 
at one-fourth the cost of arrhythmia surgery, with a markedly 
lower morbidity and virtually no mortality. 
Vf24 are not helpful in diagnosing these 2 specific types. A 
reasonable index of suspicion should be aroused with any 
tachycardia having an RBBB/superior axis or an LBBB/inferior 
axis (especially if the latter should be exercise-induced). Ulti-
mately, electrophysiologic testing may be the only reliable 
means of elucidation. Precisely defining the mechanism is 
important because for both of these forms of VT, RF catheter 
ablation might offer definitive therapy. 
Conclusion 
Currently, with cure so readily attainable with the RF ablative 
technique, empiric drug therapy is no longer the standard of care 
in most young patients with symptomatic SVT. Our cases 
demonstrate that there are 2 unusual forms of VT that also are 
amenable to catheter eradication. When confronted with a wide, 
complex tachycardia in a young person without organic heart 
disease, a healthy index of suspicion and a willingness to look 
more closely may frequently work to the benefit of the patient. 
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Classified Notices 
To place a classified notice: 
HMA members.- Please send a signed and type-
written ad to the HMA office. As a benefit of mem· 
bership, HMA members may place a complimen-
tary one-time classified ad in HMJ as space is 
available. 
Nonmembers.- Please call 536-n02 for a non-
member form. Rates are $1 .50 a word with a mini-
mum of 20 words or $30. Not commissionable. 
Payment must accompany written order. 
Services 
Are your billing methoda producing desired 
results? Pathfinder Business Services offers com-
puterized biDing and account tracking capabilities at 
reasonable prices. Free consultation. Call 625-
1085. 
Medical Billing Service& EMC claim processing, 
patient statements. We pick up and deliver accurate 
work. CaD for rates: t.4ed Con 236-0285. 
Nursing care at Home-Effective, trusted one-to-
one home health services at reasonable cost. Full 
service: companions, aides, RNs; hourly and live-
in. Also new cost-saving caregiver locator program. 
call Attention-Plus Private Nursing at 941·3313. 
Wanted 
Seeking general radiology posiUon (specialty: 
neuro) in hospital, group practice or clinic starting 
July 1, 1995. Internal Medicine graduate from UH 
and UH Residency training program. Radiology 
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Fellow in Neuro-Radiology at Cornell University 
Medical Center-The N.Y. Hospital. CV and refer· 
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glas M. Noble MD, Cornell Univ. Med. Center-The 
N.Y. Hospital, 1320 York Ave., Su~e 29M, New 
York. NY 10021 or call (212) 988·9558. 
Medical Director sought for an exciting opportunity 
in a multi-cultural, nonprofit Community Health 
center in rural coastal Dahu. The Health Center 
provides a fuN range of outpatient and emergency 
medical services for the Waianae Coast with over 
-
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1 OO,OOOpatient visits/year. Applicants must be board 
certified in a primary care specialty with 5 years of 
clinical practice and at least 3·5 years of medical 
administrative experience including managed care. 
Full benefits package and competitive salary. If 
interested, send CV by mail or fax to: Waianae 
Coast Comprehensive Health Center, Mecflcal Ad-
ministration Office, 86-260 Farrington Highway, 
Waianae, Hawaii 96792. Fax (808) 696-Q389 or 
Phone (808) 696-7081. 
For Sale 
Exam tables for sale; custom made; metal frame; 
vinyl covered. $200 ea/firm. CaD 521-3473. 
Practice for Sale 
I 
Busy OBGYN practice for sale at Kapiolani Mecfi.. 
cal Center; private office; 3 well-equipped exam 
rooms; inquiries to H. Jeni Lee 524·1800 or Fax 
524-4591. 
